The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
acceleron pharma | 919 |
celgene corporation | 20 |
adimab | 9 |
dyax corporation | 3 |
acceleron pharma inc. (us) | 1 |
acceleron pharma | 61 |
acceleron pharma | 137 |
celgene corporation | 8 |
adimab | 2 |
dyax corporation | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
activin-actriia antagonists and uses for promoting bone growth | 78 | 2005 |
activin-actrii antagonists and uses for increasing red blood cell levels | 75 | 2006 |
variants derived from actriib and uses therefor | 73 | 2007 |
activin-actriia antagonists and uses for promoting bone growth in cancer patients | 51 | 2007 |
alk7:actriib heteromultimers and uses thereof | 44 | 2015 |
use of gdf traps to increase red blood cell levels | 38 | 2008 |
activin-actriia antagonists and uses for treating or preventing breast cancer | 36 | 2007 |
methods for dosing an activin-actriia antagonist and monitoring of treated patients | 33 | 2008 |
combined use of gdf traps and erythropoietin receptor activators to increase red blood c… 🛈 | 33 | 2008 |
alk1 receptor and ligand antagonists and uses thereof | 33 | 2006 |